[144] Madrigal Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

Madrigal Pharmaceuticals, Inc. (MDGL) Form 144 notice reports a proposed sale of securities by a person for whose account shares vested as restricted stock units. The filer plans to sell two lots of Common Stock through Morgan Stanley Smith Barney LLC on 08/18/2025: 458 shares (aggregate market value $169,386.72) and 846 shares (aggregate market value $312,884.64). Both lots were acquired on 08/15/2025 by vesting of restricted stock units from the issuer. The filing states there were no sales by the filer in the prior three months and includes the required attestation about material nonpublic information.

Insights

Financial Analyst

TL;DR: Insiders propose a small, post-vesting sale of 1,304 shares executed via a broker on a single date.

The document discloses a proposed sale of 1,304 total shares acquired by RSU vesting on 08/15/2025, to be sold on 08/18/2025 through Morgan Stanley Smith Barney LLC. The filing reports aggregate market values for the two lots as provided and confirms no sales in the prior three months. Based solely on the filing, this is a routine notice required under Rule 144 documenting the insider's intention to sell shares that vested from an equity grant.

Corporate Governance Expert

TL;DR: Form 144 documents a standard, disclosed insider sale following RSU vesting, with required signature attestations.

The notice identifies the securities as common stock acquired via restricted stock unit grants from the issuer on 08/15/2025. The filer represents they are unaware of undisclosed material adverse information, and no sales were reported in the prior three months. The filing lists the executing broker and planned sale date, meeting procedural disclosure requirements under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	458	169386.72	22289014	08/18/2025	Nasdaq Stock Market
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	846	312884.64	22289014	08/18/2025	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/15/2025	Restricted Stock Unit Grant	Issuer			458	08/15/2025	Vesting of Restricted Stock Units
Common Stock	08/15/2025	Restricted Stock Unit Grant	Issuer			846	08/15/2025	Vesting of Restricted Stock Units

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the MDGL Form 144 cover?

The notice covers proposed sales of Common Stock acquired via restricted stock unit vesting.

How many MDGL shares are proposed for sale and when?

A total of 1,304 shares (458 and 846) are proposed to be sold on 08/18/2025.

How and when were the shares acquired according to the filing?

Both lots were acquired on 08/15/2025 through Restricted Stock Unit Grants that vested.

Which broker is handling the proposed sale for MDGL?

The executing broker is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, 8th Floor, New York, NY.

Did the filer report any sales of MDGL securities in the prior three months?

The filing states Nothing to Report for securities sold during the past three months.